The Clorox Company (CLX) Dividend Stock Analysis

The Clorox Company is a diversified producer of household cleaning, grocery, and specialty food products, and is also a leading producer of natural personal care products.

Source: DepositPhotos

Linked here is a detailed quantitative analysis of The Clorox Company (CLX). Below are some highlights from the above linked analysis:

Company Description: The Clorox Company is a diversified producer of household cleaning, grocery, and specialty food products and is also a leading producer of natural personal care products.

Fair Value: In calculating fair value, I consider the NPV MMA Differential Fair Value along with these four calculations of fair value, see page 2 of the linked PDF for a detailed description:

1. Avg. High Yield Price
2. 20-Year DCF Price
3. Avg. P/E Price
4. Graham Number

CLX is trading at a discount to 1.) and 3.) above. Since CLX's tangible book value is not meaningful, a Graham number can not be calculated. When also considering the NPV MMA Differential, the stock is trading at a slight premium to its calculated fair value of $91.27. CLX did not earn any Stars in this section.

Dividend Analytical Data: In this section there are three possible Stars and three key metrics, see page 2 of the linked PDF for a detailed description:

1. Free Cash Flow Payout
2. Debt To Total Capital
3. Key Metrics
4. Dividend Growth Rate
5. Years of Div. Growth
6. Rolling 4-yr Div. > 15%

CLX earned one Star in this section for 3.) above. CLX earned a Star for having an acceptable score in at least two of the four Key Metrics measured. The company has paid a cash dividend to shareholders every year since 1968 and has increased its dividend payments for 51 consecutive years.

Dividend Income vs. MMA: Why would you assume the equity risk and invest in a dividend stock if you could earn a better return in a much less risky money market account (MMA) or Treasury bond? This section compares the earning ability of this stock with a high yield MMA. Two items are considered in this section, see page 2 of the linked PDF for a detailed description:

1. NPV MMA Diff.
2. Years to > MMA

CLX earned a Star in this section for its NPV MMA Diff. of $549 This amount is in excess of the $500 target I look for in a stock that has increased dividends as long as CLX has. The stock's current yield of 5.37% exceeds the 3.75% estimated 20-year average MMA rate.

Peers: The company’s peer group includes: Procter & Gamble Co. (PG) with a 3.0% yield, Colgate-Palmolive Co. (CL) with a 2.4% yield, and Kimberly-Clark Corporation (KMB) with a 5.0% yield

Conclusion: CLX did not earn any Stars in the Fair Value section, earned one Star in the Dividend Analytical Data section and earned one Star in the Dividend Income vs. MMA section for a total of two Stars. This quantitatively ranks CLX as a 2-Star Weak stock.

Using my D4L-PreScreen.xls model, I determined the share price would need to increase to $95.46 before CLX's NPV MMA Differential decreased to the $500 minimum that I look for in a stock with 51 years of consecutive dividend increases. At that price the stock would yield 5.2%.

Resetting the D4L-PreScreen.xls model and solving for the dividend growth rate needed to generate the target $500 NPV MMA Differential, the calculated rate is 0.1%. This dividend growth rate is lower than the 0.4% used in this analysis, thus providing a small margin of safety. CLX has a risk rating of 1.50 which classifies it as a Low risk stock.

As a consumer goods company, CLX sells products with a stable demand that are generally not affected by changes in the economy. Its products are well known and include popular brands such as: Fresh Step, Brita, Glad, Pine-Sol, Hidden Valley, Scoop Away, K C Masterpiece, S.O.S., Kingsford, Tilex, Formula 409, Liquid-Plumr, and its namesake Clorox. The company's presence in the natural home/personal care products arena through Burt's Bees and GreenWorks is viewed positively by environmentalists.

The company's Debt To Total Capital is 96% (flat with my previous review), and its Free Cash Flow Payout is 151% (down from 96% in the previous review), both are well outside my acceptable range. The stock is trading above my calculated fair value of $91.27, thus I will not be a buyer in the near-term.

STOCKS IN THIS ARTICLE

Also Mentions:

Comments